Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Richman

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer|December 24, 1997
Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinomaS J DeNardo, L A Kroger, K R Lamborn, et al.
Journal of Clinical Apheresis|January 1, 1994
Sequential transplants using mobilized peripheral blood progenitor cellsR Ghalie, C M Richman, J G Bender, et al.
Anticancer Research|January 19, 1999
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocolS J Denardo, C M Richman, D L Kukis, et al.
Anticancer Research|May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancerS J Denardo, C M Richman, D S Goldstein, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantationR Ghalie, C M Richman, S S Adler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenograftsG L DeNardo, L A Kroger, C F Meares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin AC M Richman, S J DeNardo, R T O'Donnell, et al.
Anticancer Research|May 1, 1997
Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibodyS J Denardo, L F O'Grady, C M Richman, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer|December 24, 1997
Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinomaS J DeNardo, L A Kroger, K R Lamborn, et al.
Journal of Clinical Apheresis|January 1, 1994
Sequential transplants using mobilized peripheral blood progenitor cellsR Ghalie, C M Richman, J G Bender, et al.
Anticancer Research|January 19, 1999
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocolS J Denardo, C M Richman, D L Kukis, et al.
Anticancer Research|May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancerS J Denardo, C M Richman, D S Goldstein, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantationR Ghalie, C M Richman, S S Adler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenograftsG L DeNardo, L A Kroger, C F Meares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin AC M Richman, S J DeNardo, R T O'Donnell, et al.
Anticancer Research|May 1, 1997
Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibodyS J Denardo, L F O'Grady, C M Richman, et al.
Pageof 5